Columvi (glofitamab)

Australian Public Assessment Report

AusPAR

AusPAR: Columvi [PDF, 1.6 MB]

AusPAR: Columvi [Word, 2.65 MB]

Attachment: Product information for Columvi [PDF, 285.96 KB]

Attachment: Product information for Columvi [Word, 371.06 KB]

Device/Product Name

Columvi

Active ingredients

Glofitamab

AusPAR Date

18 December 2024

Published

28 February 2025

Submission Number

PM-2022-01989-1-6

Submission Type

New biological medicine

Decision

Approved